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Abstract
Objective: Industrialized countries are currently experiencing an epidemic of high
blood pressure (HBP) extending to people living with HIV (PLWH). Given the
prevalence of hazardous alcohol use (HAU), this study examines the relationship
between alcohol consumption and hypertension in PLWH. Including a gender
analysis is critical, given the high rates of HAU and HIV among females.
Method: We followed PLWH including both HAU and non-HAU (200 each).
Participants were assessed twice for body weight, blood pressure, alcohol
consumption, and other BP-associated lifestyle factors. High blood pressure
(defined as systolic/diastolic blood pressure above 140/90 mmHg and/or treatment
of HBP) was the primary outcome.
Results: Overall prevalence of hypertension was 38% and higher among HAU
compared to non-HAU (42% vs. 34%, p50.02). Less than half with HBP (42%)
were receiving treatment for hypertension. Overall, males had a 50% higher risk of
HBP than women (odds ratio: 1.5, 95% CI: 1–2.6, p50.05). However among HAU,
females were twice as likely to suffer HBP as their male counterparts (95% CI:
1–3.9, p50.02). Those HAU who preferred liquor, versus wine, had higher adjusted
mean BP (132.6¡18 vs. 122.3¡14 mm Hg, p50.05). Additional analyses
indicated that consumption of .1 standard drink of liquor or beer/day was
associated with HBP. Risk of hypertension was noted in those with daily
consumption of .3 glasses of wine. For those reporting ,1 drink per day, the odds
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ratio of having HBP was 0.97 (CI: 0.6–0.99, p50.05). Factors associated with
hypertension in the multivariate model included increased age, gender, BMI, HAU
particularly of liquor, and smoking.
Conclusions: Excessive hypertension burden in this population and its association
with HAU and sub-optimal care indicate the need for preventive and educational
intervention in PLWH. Analyses highlight the necessity of gender and type-ofbeverage specific approaches.

Introduction
After the increased longevity achieved with the success of antiretroviral therapy
(ART), HIV experts are now concerned with the increased risks of cardiovascular
diseases (CVD) observed among people living with HIV (PLWH). For PLWH,
rates of CVD are approximately two-fold higher than for age-matched people
without HIV infection. [1–2] Nonetheless, studies evaluating weather hypertension is more prominent among PLWH have reached controverting conclusions
[3–7]. The contradictory findings in the burgeoning literature are likely related
not only to different study designs or populations, but also the accrual of risk
factors.
Several epidemiological studies among the general population have documented a close relationship between alcohol consumption and systemic hypertension
[9]. Indeed, a linear dose-response relationship has been identified [10–12]. In
other studies, the relationship has been non-linear, especially in women. Notably,
some authors have proposed that moderate consumption of alcohol may be
cardioprotective by reducing blood pressure [13]. Nonetheless, some methodological limitations exist. Few studies were longitudinal, and data regarding the
plausible effects of the type of alcoholic beverage have been insufficiently assessed
[14]. Many of these studies have failed to analyze body composition, although it is
known that hypertension commonly clusters with obesity [8]. While the
association between HAU and HBP has been investigated exhaustively in
populations across the globe, few studies have been conducted in PLWH.
Including women in this type of study is critical because HBP is a significant
risk factor for CVD, which is the leading cause of death in women. Every minute
in the United States, a woman dies from a CVD. Notably, while in younger adults
(,45 years of age), HBP rates are higher among males than females, and with
aging the proportion of women with hypertension starts rising and surpasses
those of the male counterparts. [15] Given that the risk of CVD doubles for every
20 mmHg increase in systolic BP, or 10 mmHg increase in diastolic BP,
hypertension could be a serious contributor to gender differences in morbidity
and mortality. Therefore, analyses of gender differences regarding the prevalence,
treatment, and control rates of hypertension are of public health significance.
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This study aims to address these important issues by examining the
relationships between alcohol consumption and HBP among men and women
living with HIV. The PADS (Platelets Mediating Alcohol and HIV Damage Study)
cohort provides a unique opportunity, not only because detailed information on
alcohol use was collected, but also because of the large participation of women
and minority individuals. In addition, PADS was heterogeneous regarding
beverage preference and therefore an ideal cohort to obtain the most informative
data regarding high-risk groups and correlates of risks. This information is
necessary to develop effective prevention and treatment programs.

Methods
Sampling
The PADS is a large, single-site multi-ethnic cohort consisting of 400 PLWH, who
are at least 18 years old and under regular care at Miami’s primary open-access
public health system. Recruitment and assessments took place in the period
between June 2010 and June 2012. Our choice of PLWH in an open-access public
health system with standard treatment protocols was purposefully designed to
minimize social, medical, and treatment inequalities.
Males and females with confirmed HIV infection were eligible. Nonambulatory patients, and those presenting with major medical co-morbidities
such as major neuropsychological (i.e., active central nervous system opportunistic infection, tumors, developmental disorders), immune-based (i.e., malignancies, autoimmune diseases), and chronic diseases (i.e. renal failure) were not
included. In addition, subjects who had cirrhosis, active viral hepatitis, or liver
enzymes two standard deviations above normal values were not eligible. To reduce
the confounding effects of illicit drug use, the DSM-IV-TR questionnaire was
applied, and those individuals who were dependent on drugs or injecting illicit
psychoactive substances were excluded.

Participants’ Assessment Protocol
PADS was approved by the Institutional Review Boards at Florida International
University and University of Miami. The study was conducted according to the
principles expressed in the Declaration of Helsinki. Those participants who
provided written informed consent were consecutively enrolled and followed over
a period of six months.

Measures
Outcome Variable –Hypertension

Blood pressure was measured by a health care provider at the research center
using a calibrated automated machine in an upright position. After the participant
had rested at least five minutes, systolic and diastolic measurements were
registered at the first and fifth Korotkoff sounds. Following national guidelines,
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two readings were performed at each visit using Sure sign VS2 (Phillips), and the
average was recorded. Hypertension was defined using the World Health
Organization (WHO)/International Society of Hypertension (ISH) guidelines:
diastolic blood pressure (DBP) values of $90 mm Hg or systolic blood pressure
(SBP) values of $140 mmHg at the two clinic visits (i.e., baseline and 6 months).
Following the Current Joint National Committee 7 guidelines, HBP was further
subdivided into: Stage 1 (SBP 140-159 or DBP 90–99 mm Hg) and Stage 2 (SBP
.160 or DBP .100 mm Hg) [18]. Subjects being prescribed an antihypertensive
medication, irrespective of blood pressure, were also defined as hypertensive. Data
on prescribed medications and history of HBP were collected by using
standardized questionnaires and confirmed with medical records when available.
Alcohol Use Profiling

Since the main focus of this cohort study was to assess the potential effects of
alcohol, participants were dichotomized as hazardous and non-hazardous alcohol
users. To classify participants, alcohol intakes were collected using the Alcohol
Use Disorders Identification Test (AUDIT) and the Alcohol Dependence Scale
(ADS) [16–17]. To isolate the impact of different types of alcohol consumption
on the risk of HBP, participants were queried regarding their predominant type of
alcoholic beverage (i.e., $75% of all times: beer, wine, or liquor). This
information is highly relevant in light of prior publications indicating differential
health effects by type of alcoholic beverage [19–20]. A standard drink was defined
as 12 fluid ounces of beer, 5 fluid ounces of wine, or 1.5 fluid ounces of distilled
spirits (equivalent to 0.5 ounces or 14 grams of alcohol). Alcohol consumption
scores were computed by averaging cross products of quantity and frequency of
beer/wine and hard liquor reported on the ADS responses.
Subsequently, based on the National Institute of Alcohol Abuse and Alcoholism
guidelines criteria and using gender specific criteria, participants were classified as
HAU, while those who reported fewer drinks were categorized as non-HAU.
Specifically, men who reported .2 drinks per day (14 drinks/week) and women
reporting more than one drink per day (or binge drinking .3 drinks in one day)
were classified as HAU.

Potential Confounders
Other measures included sociodemographics (i.e., gender, age, race/ethnicity,
income, and education), smoking (the Fagerström Test for Nicotine
Dependence), and total dietary intake (24 hour dietary intake). Basic body
composition indices including weight and height to calculate body mass index
(BMI; weight [lbs]/height [inches]2 6703) were obtained.
Since it is not clear whether HIV or a specific ART is an independent risk factor
for hypertension, we quantified CD4 counts and HIV viral load (Amplicor HIV
monitor test, Roche Diagnostic System). We also documented ART and
adherence using both self-report and medical chart abstraction (ACTG
questionnaire).
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Statistical Analyses
The data were analyzed using SPSS 20 (IBM, Inc., Chicago, IL), and p values
,0.05 were considered to be statistically significant. Means were compared using
Student’s t-test and one-way analysis of variance (ANOVA) procedures.
Univariate analyses were used to calculate odds ratios (OR) and 95% confidence
intervals (CI). Logistic regression analyses were used to evaluate the effects of
alcohol (continuous or as hazardous vs. non-hazardous), BMI (continuous and
dichotomized as .30), age (continuous and dichotomized at age 40), and gender
on BP.
The multivariate model that examined factors associated with HBP included all
covariates that were significant in the univariate models plus other potential
predictors (i.e., age, gender, race/ethnicity, CDC HIV disease status, BMI, alcohol
use, and ART) selected on the basis of the HIV medical literature. More
parsimonious models were explored by removal of covariates, one at a time,
starting with the covariate with the largest p value, until the final full model was
achieved.

Results
The mean SBP of the group at baseline was 122.9¡15.2 mm Hg and the mean
DBP was 77¡11. At the last visit, SBP was 123.5¡16 mm Hg and DBP was
78.6¡10 mm Hg. The prevalence of hypertension in our study cohort was high
with 38% having HBP. Less than half of those with repetitive blood pressure
readings above the recommended limits (140/90 mm Hg) at baseline (45%) and
at the last visit (48%) were receiving treatment. However, an additional 20% were
prescribed a medication and were not taking it.

Bivariate analyses
As in the general population, hypertensive subjects were older. Significant
differences by age groups were evident between persons . age 40 compared to age
40 and younger for both SBP (124.1¡15.7 vs. 118.8¡12.8 mm Hg, p50.004) and
DBP (78.1¡11.3 vs. 75.2¡9.7 mm Hg, p50.04). As depicted in Table 1 analyses
uncovered gender differences, including in mean SBP (men 5123.9¡14 vs.
women 5121.0¡16.3 mm Hg, p50.07). Overall, males had a 50% higher risk of
HBP than women (OR: 1.5, 95% CI: 1–2.6, p50.05). Hypertensive women were
less likely to be receiving treatment for their HBP (OR50.76, 95% CI: 0.4–1.1,
p50.05).
Compared to eutrophic subjects, obese individuals had the highest mean SBP,
both at baseline (127.4¡14 vs. 121.2¡16.2 mm Hg, p50.0001) and at the followup visit (129.1¡13 vs. 120.3¡19 mm Hg, p50.001). DBP also differed between
obese and non-obese individuals (81.4¡9 vs. 76.1¡10, p50.001). They were also
more likely to be HAU (82%) than others. Next, we assessed the prevalence of
hypertension across categories of BMI and found that obese individuals were 4
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Table 1. Sociodemographic and Clinical Characteristics of HIV-infected Patients by Gender.
Variable

Male

Females5110

16¡7

18¡7

0.09

42.3¡6.9

42.8¡5.7

0.44

26.6¡6.0

31.7¡8.6

0.00

Albumin mg/dl

4.2¡0.5

4.1¡0.4

0.01

CD4 Cell Countsb

386.3¡257

508.7¡315

0.00

Viral Load (log)b

2.8¡1.3

2.7¡1.4

0.30

HIV Diagnosis Year (mean)

a

Age (years)a
BMI kg/m2b
b

P value

Systolic Pressure mmHg

123.9¡14.5

121.0¡16.3

0.07

Diastolic Pressure mmHg

77.3¡10.5

77.7¡11.8

0.79

Total drinks per week

18.7¡2

12.7¡2

0.02

a

Demographic characteristics were expressed as percentages by gender groups.
Biological measures were presented as means and standard deviations.

b

doi:10.1371/journal.pone.0113122.t001

times more likely to have stage 2 hypertension (95% CI: 1–19.9, p50.04).
Overweight individuals also had higher odds of HBP, when compared to
eutrophic individuals (OR: 2.4, 95% CI: 1.3–4.3, p50.002).

Blood Pressure and HIV-related Factors
Hypertensive and normotensive individuals were comparable in terms of numbers
of years living with HIV infection. Given prior postulates that ART increases the
risk for the development of hypertension, we explored this relationship [22–23].
However, the prevalence of HBP was similar between those receiving or not
receiving ART (33% vs. 27%). Mean SBP was also similar between those receiving
Truvada (121¡15 vs. 124¡16 mm Hg, p50.06), Norvir (122¡16 vs.
123¡14 mm Hg, p50.7), and Atripla (123¡15 vs. 122¡15 mm Hg, p50.7),
versus those who did not. Neither was the number of years receiving ART (8 vs. 7
years, p50.2), so no further analyses were performed. We did not observe a
significant relationship between duration of HIV infection and HBP [see Table 2].
Though in the past longer duration of HIV infection has been associated with
HBP, we failed to observe any significant difference [see Table 2]. As depicted in
Table 2, subjects with stage 2 HBP had the lowest viral loads, but not to a
significant extent. Supplementary analyses indicated that those who had achieved
undetectable viral loads had significantly higher SBP (124.7¡15.5 vs.
120.2¡14.7 mm Hg, p50.005). The diastolic blood pressure was also different
(78.4¡11.8 vs. 75.9¡9.7 mm Hg, p50.03).
Although baseline CD4 count as a continuous variable showed no significant
associations with hypertension, when the sample was dichotomized above and
below 200 CD4 cells, differences emerged. Subjects with CD4 counts .200 cells/
mm3 were more likely to have HBP, (OR: 1.7, 95% CI: 1–3.1, p50.03).
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Table 2. Baseline Sociodemographic Information of HIV-infected Patients by BP Groups.
Variable
HIV Diagnosis Year (mean)

a

Normotensive n5260

Stage 1 Hypertension n5110

Stage 2 Hypertension n530

P value

17¡1.4

17¡1.8

18¡1.3

0.9

Age (years)a

41.7¡6.9

43.7¡5.7

46.2¡4.0

0.009

Mena

61%

69%

59%

0.3

Women

a

39%

31%

41%

0.3

African Americana

69%

70%

88%

0.5

Hispanica

24%

24%

12%

0.5

7%

6%

0%

0.5

Less than $10,000

88%

87%

76%

0.7

$11,000–$49,000

9%

7%

17%

0.7

.$50,000

3%

6%

17%

0.7
0.09

a

White

Annual Income:a

2b

BMI kg/m

27.6¡6.7

30.1¡8.3

31.6¡9.8

Smoking (cigarettes/day)b

3.1¡1.5

8.1¡1.3

8.8¡0.7

0.03

CD4 Cell Countsb

428¡283

473.0¡306

394¡242

0.1

Viral Load (log)b

2.8¡1.3

2.6¡1.22

2.3¡0.86

0.4

Systolic Pressure mmHg

120.5¡14

143.5¡4.8

168.9¡11.9

0.000

Diastolic Pressure mmHg

75.6¡13

90.1¡4.6

96.3¡22.6

a

Demographic characteristics were expressed as percentages by blood pressure groups.
Biological measures were presented as means and standard deviations.

b

doi:10.1371/journal.pone.0113122.t002

Alcohol Use and Blood Pressure
Though among non-HAU over half (55%) never or rarely drank alcoholic
beverages, 34% imbibed at least once a week, typically more than two drinks per
occasion. HAU were actively drinking at the time of assessment and imbibed in
excess of 7¡5 drinks per day. They regularly consumed alcohol an average of 4
days a week, and the mean total intake was 31 drinks per week. Table 3 shows the
descriptive characteristics of the total sample by alcohol status. As depicted in
Table 1, HAU were more likely to be smokers. Smokers had a 60% higher risk of
having HBP (OR: 1.6, 95% CI 1–2.5, p50.01). Notably, HAU that smoked almost
doubled their risk (OR: 2.6, 95% CI 1.3–5.14, p50.002).
Overall prevalence of hypertension was 38% and higher among HAU compared
to non-HAU (42% vs. 34%, p50.02). The SBP of HAU was significantly higher
than that of non-HAU (124.5¡14 vs. 121.2¡15.6 mm Hg, p50.04), yet the DBP
was only marginally higher (78.3¡10.1 vs. 76.7¡11.8 mm Hg, p50.09). HAU
exhibited higher odds of HBP compared with non-HAU (OR: 1.4, 95% CI: 1.03–
1.87, p50.01). Gender analyses revealed, that among HAU, women were twice as
likely to have HBP, compared to their male counterparts (95% CI: 1–3.9, p50.02).
In addition, HAU females exhibited much higher OR of having HBP than the
non-HAU women (OR: 3, 95% CI: 1.3–5.8, p50.004).
The number of drinks per day was related to blood pressure. Subjects drinking
more than 1 drink per day exhibited significantly higher systolic and diastolic
blood pressures, compared with those drinking ,1 drink per day, 3.6 mm Hg
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Table 3. Sociodemographic and Clinical Characteristics of HIV-infected Patients by Alcohol Groups.
Variable

HAU N5198

Non-HAU N5199

P value

Age (Years)

43¡6.4

41¡6

0.7

Mena

67%

60%

0.1

Womena

33%

40%

0.1

African American

70%

66%

0.4

Black Caribbeana

2%

4%

0.4

Hispanica

22%

23%

0.4

6%

7%

0.4

Less than $10,000

88%

86%

0.7

$11,000–$20,000

8%

10%

0.7

$20,000–$49,000

2%

2%

0.7

.$50,000

2%

2%

0.7

Education (years of school)a

11.5¡2

11.3¡2.4

0.1

4¡0.4

4.1¡0.5

0.9

2379.6¡1214

2042.1¡968

0.1

29.3¡7.9

27.6¡7.0

0.03

408¡259

455¡310

0.1

Viral Load (Log)

2.7¡1.3

2.6¡1.3

0.4

Systolic Pressure mmHg

124.5¡14.7

121.120¡15.6

0.03

Diastolic Pressure mmHg

78.3¡10.1

76.6¡11.8

0.2

a

a

a

White

Annual Income:a

Albumin mg/dlb
Total Caloric Intake (Kcal/day)

b

BMI kg/m2b
CD4 Cell Countb
b

a

Demographic characteristics were expressed as percentages by alcohol groups (except for Education).
Biological measures were presented as means and standard deviations.

b

doi:10.1371/journal.pone.0113122.t003

(systolic 123.95¡14.8 vs. 120.3¡15.9 mm Hg, p50.05 and diastolic 78.4¡10.5
vs. 75.1¡11.8 mm Hg, p50.05, respectively).
Since Marmot et al. discovered a significant relationship between drinking
more than three drinks per day and HBP, a similar analysis was performed [21].
Similar to Marmot’s study, drinkers of more than 3 drinks per day tended to have
higher unadjusted risks of hypertension, compared with other drinking categories
(OR: 1.2, 95% CI: 0.9–1.68, p50.07). The difference between the BP level of those
consuming 1–3 drinks per day, compared with abstainers was 4.0 mm Hg
(124.1¡14.9 vs. 120.9¡15.5, p50.05 mm Hg), yet DBP did not differ.
Type of beverage was also associated with blood pressure. Liquor use was
reported by a third of the drinkers, beer by 45%, 22% reported preferences for
wine and the remaining 10% indicated not preferences. For predominant beverage
consumption, HAU liquor drinkers on average showed a higher SBP (130.2¡13
vs. 122.6¡15.5 mm Hg, p50.045), compared to non-liquor drinkers. On the
other hand, no significant differences in SBP (123.8¡14 vs. 119.0¡13 mm Hg)
or DBP (78.2¡10 vs. 72.0¡6.2 mm Hg) were found among HAU and non-HAU
of other alcoholic beverages. The relationship between liquor and SBP remained
significant after controlling for confounders (i.e., age, gender, race, diet, and
physical activity). To gauge the extent to which the type of beverage was related to

PLOS ONE | DOI:10.1371/journal.pone.0113122 December 9, 2014

8 / 14

Gender Differences in Hazardous Alcohol Use with Hypertension

hypertension risk in a dose-response fashion, we sorted respondents according to
the number of drinks consumed per occasion. If the subject consumed more than
3 cups of wine per day, then a significant deleterious effect of BP was observed
(126¡15 vs. 122.3¡14 mm Hg, p50.05), but even in this case liquor drinkers
exhibited the highest SBP values. No significant differences were evident among
beer users.
Finally, a slightly higher proportion of HAU that were hypertensive were not
taking any medication (58%) as compared to non-HAU in whom 50% were
taking their medication.

Multivariable Analyses
Since we aimed to assess the relationship among specific types of alcohol
consumption, hypertension, and gender, we examined predictors of hypertension
in 4 separate models (the first model in HAU: Table 4; the second in non-HAU:
Table 5; in men: Table 6; and in women: Table 7). As illustrated in Table 3, in
addition to receiving treatment, other factors significantly associated with
hypertension among non-HAU were increasing age (p50.01), male gender
(p50.02), higher BMI (p50.03), and liquor use (p50.01). In the second model
for HAU, two distinct factors were significantly associated with hypertension:
female gender and smoking. Notably in the gender models, alcohol, specifically
liquor and smoking, remained as significant predictors only among females. Of
interest, none of the HIV specific variables remained significant in any of the
models.

Discussion
Our analyses revealed a prevalence of hypertension (38%) that is higher than
previously reported for PLWH (8–34%) and age-matched rates in the general
population (33%). Of concern, less than half of those with elevated BP readings in
the study were receiving treatment. Noteworthy, another 20% were prescribed
treatment but were not taking it, possibly because of the burden of pills and the
usual asymptomatic nature of the disease. These rates are of great concern, given
that hypertension places stress on the vasculature, kidneys, and heart, which could
result in arrhythmia, heart failure, cardiomyopathy, valvular disease, kidney
failure, and stroke. Therefore, understanding factors associated with hypertension,
especially reversible behaviors such as smoking and drinking, has high public
health relevance. In this regard, our data demonstrated that HAU is an important
predictor of HBP. Furthermore, the data provide further directives, as results
highlight the importance of limiting alcohol intake to one drink per day.
Educating PLWH regarding the harms of HAU, particularly the risks of CVD,
should be an important component of disease prevention. Overall, the model also
suggests that the previously proposed role of ART on risk of HBP is either small or
affects only a limited proportion of susceptible subjects. Our initial observation
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Table 4. Multivariate Analyses among Non-hazardous Alcohol Users.
Model

Unstandardized Coefficients

Standardized Coefficients

B

Std. Error

Beta

1

(Constant)

.732

.156

BMI

.062

.029

.113

Age 40

.135

.052

Gender male

.111

.050

HBP treatment

.291

Liquor

2.022

a

t

P value

4.705

.000

2.136

.033

.128

2.571

.011

.114

2.204

.028

.060

.243

4.827

.000

.009

2.124

22.488

.013

a

Dependent Variable: Hypertension at the last visit (yes/no).

doi:10.1371/journal.pone.0113122.t004

might be attributable to BMI, since HIV-related variables were no longer
significant once we incorporated BMI and HAU into the model. These findings
highlight the importance of focusing on primary prevention and therapy on
subjects with alcohol, smoking, and obesity comorbidities. By doing so, the
detection of other CVD risk factors can also be improved.
Our results indicated that outcomes appear to be gender specific, and therefore
failure to conduct gender analyses can lead to incorrect conclusions. We found
that males are at greater risk for developing hypertension than are age-matched
women. Findings are in accord with prior studies among the general population,
which have attributed disparities in hypertension rates to the protective effects of
hormones [24–25].
Yet, our most important finding lies in discovering that HAU-women have
higher rates of HBP, suggesting that they may be more susceptible to the
vasopressor effects of alcohol. Differences could be attributed to the higher rates
of obesity among hazardous drinking women, but not among men, in whom
drinking was rather associated with low BMI. Obesity is known to exacerbate the
risks of hypertension and could explain the observed gender differences. Finally,
gender differences in treatment rates were also evident with women being less
likely to be taking treatment for HBP. Though participants in our study were all
Table 5. Multivariate Analyses among Hazardous Alcohol Users.
Model

1

(Constant)

Unstandardized Coefficients

Standardized Coefficients

B

OR

Std. Error

Beta

2.130

0.88

.190

t

P value

2.682

.496
.010

BMI

.066

1.07

.026

.116

2.585

Age 40

.099

1.10

.047

.090

2.123

.034

Gender male

.103

1.11

.045

.101

2.305

.022
.000

HBP treatmenta

.668

1.95

.053

.533

12.488

Smoking

.108

1.13

.044

2.104

22.449

.015

Liquor

.146

1.16

.063

.099

2.326

.021

a

Dependent Variable: Hypertension at the last visit (yes/no).

doi:10.1371/journal.pone.0113122.t005
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Table 6. Multivariate Analyses: Predictors of Blood Pressure among Men.
Model

Unstandardized Coefficients
B

Std. Error

Beta

BMI

.433

.167

Age

.300

.137

HBP treatment

a

Standardized Coefficients

t

P value

.176

2.593

.000

.144

2.189

.010

28.429

2.67

2.214

23.154

.002

Number of cigarettes

2.058

.075

2.049

2.771

.442

Liquor

0.524

.338

.102

1.549

.123

a

Dependent Variable: Systolic Blood Pressure as a Continuous Variable.

doi:10.1371/journal.pone.0113122.t006

involved in health care, it is possible that low income among women may impact
their capability to obtain medication(s).
Equally important, our study provides significant evidence regarding the
differential influences of type of alcoholic beverage on rates of systemic
hypertension. After adjustment for key confounding factors, such as general
health, diet, and social and economic variables, liquor use conferred greater BP
risks than beer or wine in this sample. Of concern, SBP, which was particularly
higher among liquor users, is a better predictor of risk for cardiovascular and
renal disease than DBP [26]. Findings are consistent with prior publications
[27–30]. Leighton and colleagues[27] attributed the vascular differences among
liquor, beer, and wine to flavonoids and polyphenols, which enhance endothelial
nitric oxide synthase expression and subsequent nitric oxide release from
endothelial cells [27–28]. On the other hand, alcohol, which in this case equates to
liquor (alcohol without antioxidants, resveratrol), has been associated with
suppressed bioavailability of nitric oxide. In addition, antioxidants and other
secondary components of wine and beer can also enhance flow-mediated
vasodilatation [28–29]. Yet, it is important to remember that for those individuals
consuming more than 3 drinks of wine or beer daily the beneficial effects
disappear, probably because the balance between alcohol and antioxidants is lost.
Yet, regardless of the mechanism(s), the public health and clinical message is clear:
Table 7. Multivariate Analyses: Predictors of Blood Pressure among Women.
Model

Unstandardized Coefficients

Standardized Coefficients

t

P value

B

Std. Error

Beta

1 BMI

.433

.145

.238

2.975

.004
.006

Age

.555

.198

.223

2.804

HBP treatmenta

210.146

2.767

2.285

23.667

.000

Number of cigarettes

2.329

.131

2.194

22.511

.013

Liquor

1.087

.491

.171

2.216

.029

Wine

20.72

1.000

2.006

2.072

.943

Beer

.255

.490

.042

.520

.604

a

Dependent Variable: Systolic Blood Pressure at the last visit, as a Continuous Variable.

doi:10.1371/journal.pone.0113122.t007
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the use of alcohol is an important risk factor for hypertension, particularly if
liquor is used.
Of concern is the confluence of HAU, obesity, and smoking, which at least
doubled the risk for HBP in this population. These results highlight the need for
global prevention approaches; otherwise the survival benefits of ART will be soon
offset. Noteworthy, none of the HIV parameters (ART, CD4, or viral load)
remained as significant predictors of hypertension. Findings are in line with large
clinical trials, though others have argued that ART, low CD4, and viral load can
influence the odds of hypertension. Because obesity could be associated with ART
and better CD4 and viral responses, higher BMI will be the direct contributor to
hypertension.
Our results need to be analyzed with some caveats. For example, our study is
based on a single site cohort in Florida. Yet, results are consistent with national
cohorts, as well as with scientific reports around the globe, which argue for the
applicability of our findings. Second, while the collection of alcohol data was very
detailed, alcohol intakes were obtained by self-reports only, which is considered a
common drawback, given the risks of either under or over-estimation.
On the other hand, this study has several strengths. First, a single site cohort
allows health status?, social systems, education, and health policy to be relatively
homogeneous, and therefore the confounding effects of these variables in our
study are significantly reduced. Our cohort includes a large number of women
and minorities who are not well-represented in other studies. This large
participation of women allows for a relatively well-balanced sample to pursue
gender analyses and to uncover the enhanced risks of HIV+ hazardous alcohol
user females. As the face of the alcohol abuse epidemic is changing with women’s
rate rising, the need to understand gender differences has never been more
necessary; particularly as women are now consuming not only larger amounts, but
also different types of alcoholic beverages. The detailed information regarding
alcohol intakes provides invaluable data to comprehensively analyze risks by type
of alcoholic beverage. Thanks to these advantages, this study allows us to identify
populations at high risk of hypertension, including liquor users, women, and
smokers that need to be prioritized in prevention campaigns. Interventions to
reduce alcohol and smoking among PLWH are of prime importance both for
individual prognosis and public health success.
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